BioLife4D

Early Stage

Build a Heart. Save a life.

Overview

Raised to Date: Raised: $275,333

Total Commitments ($USD)

Platform

Dalmore Group

Start Date

10/23/2020

Close Date

10/23/2021

Min. Goal
$1,080
Max. Goal
$46,133,806
Min. Investment

$1,080

Security Type

Equity - Common

SEC Filing Type

RegA+    Open SEC Filing

Price Per Share

$13.50

Rolling Commitments ($USD)

Status
Funded
Reporting Date

10/31/2021

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$754

# of Investors

82

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2016

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Location

Buffalo Grove, Illinois

BioLife4D is raising funds on Dalmore Group through Reg A+ crowdfunding. The company aims to use the current advances in cardiac tissue engineering to build human hearts suitable for implantation. The company will use 3D bioprinting to make patient-specific hearts using the patients’ own cells. The hearts of BioLife4D will have a precise fit and a perfect genetic match. BioLife4D has printed a mini-heart and working on a functional mini-heart for toxicity testing. Steven Morris founded BioLife4D in 2016. The current crowdfunding campaign has no minimum target and a maximum target of $46,133,806. The campaign proceeds will be used for marketing, salaries, rent, equipment, licenses, and working capital.

Balance Sheet

Cash and Cash Equivalents

$1,337,468

Total Assets

$1,376,956

Accounts Payable & Accrued Liabilities

$34,077

Long Term Debt

$850,000

Total Liabilities

$978,580

Total Stockholders' Equity

$398,376

Total Liabilities and Equity

$1,376,956

Statement of Comprehensive Income Information

Costs & Expenses Applicable to Rev

$1,504,757

Net Income

$-1,569,796

Earnings Per Share - Basic

$0.00

Earnings Per Share - Diluted

$0.00

Auditor: IndigoSpire
Financials as of: 10/23/2020
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.

Create your first portfolio

Create your own startup investment portfolio on KingsCrowd.

Track all of your startup investments in one place using our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
BioLife4D on Dalmore Group 2020
Platform: Dalmore Group
Security Type: Equity - Common
Price per Share: $13.50

Follow company

Follow BioLife4D on Dalmore Group 2020

Buy BioLife4D's Deal Report

Warning: according to the close date for this deal, BioLife4D may no longer be accepting investments.

BioLife4D Deal Report

Get KingsCrowd’s comprehensive report on BioLife4D including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether BioLife4D is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the BioLife4D deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge Pro